午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

ChemicalBook Chinese Germany Japanese Korean

BOC Sciences Company Information
Company Name:    BOC Sciences
Tel:    -16314854226;
Email:    inquiry@bocsci.com
Nationality:    United States
WebSite:    https://www.bocsci.com/
Product List:    19654
143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197
Product List
MART-1 (24-33(34))
MAGE-2 (127-136)
MAGE-1 (62-70)
MAGE-1 (268-282)
MAGE-1 (222-231)
lymphocyte antigen 6 complex locus K (61-84)
MAGE-1 (289-298)
Lengsin (270-279)
MAGE-12 (170-178)
MAGE-3 (111-125)
L-Homocarnosine dihydrochloride 1807885-26-2
Mammaglobin-A (23-31)
MART-1 (100-111)
Mammaglobin-A precursor (2-10)
MAPK/MAK/MRK overlapping kinase (352-360)
MAPK/MAK/MRK overlapping kinase (32-40)
MAGE-6 (290-298)
MAGE-6 (293-301)
MAGE-9 (223-231)
MART-1 (100-116)
MAPK/MAK/MRK overlapping kinase (11-20)
MAGE-4 (156-163)
MAGE-3 (168-176)
MAGE-3 (113-121)
MAGE-3 (167-176)
MAGE-3 (161-175)
MAGE-1 (90-104)
MAGE-3 (114-122)
MAGE-3 (119-134)
MAGE-4 (143-151)
MAGE-6 (121-134)
MAGE-1 (102-112)
lymphocyte antigen 6 complex locus K (119-128)
L-lactate dehydrogenase A chain (254-265)
Mammaglobin-A precursor (32-40)
Mammaglobin-A precursor (4-12)
LXW7 1313004-77-1
M-2420 310427-95-3
MART-1 (100-114)
MAGE-3 (243-258)
MAGE-3 (112-120)
Melanoma-associated antigen C1 (1083-1091)
Melanoma-associated antigen C2 (42-50)
Melanoma-associated antigen C2 (43-57)
Melanoma-associated antigen C2 (336-344)
Melanoma antigen preferentially expressed in tumors (425-433)
MAGE-1 (230-238)
Melanoma antigen preferentially expressed in tumors (100-108)
MART 1 peptide (1-10)
MART-1 (51-73)
Matrix protein 1 (27-35)
MART-1 (97-116)
Melanocyte protein Pmel 17 precursor (46-57)
MART-1 (32-40)
MART-1 (91-110)
Melanocyte protein Pmel 17 precursor (44-57)
Matrilysin (96-107)
MAGE-3 (143-151)
Matrix protein 1 (229-237)
MAGE-3 (191-205)
MAGE-1 (96-104)
MAGE-1 (278-286)
MART-1 (51-61)
Melanocyte protein Pmel 17 precursor (45-57)
Melanoma antigen gp100 (280-288)
Melanocyte protein Pmel 17 precursor (40-57)
melanoma-overexpressed antigen 1 (11-23)
MAGE-10 (290-298)
MAGE-12 (127-141)
MAGE-10 (254-262)
Melanoma-associated antigen C1 (137-149)
Melanoma antigen preferentially expressed in tumors (301-309)
Melanoma-associated antigen C2 (307-315)
Melanoma-associated antigen C1 (959-968)
Melanoma-associated antigen C1 (779-787)
Melanoma antigen preferentially expressed in tumors (300-309)
Melanoma-associated antigen C1 (450-458)
Melanoma-associated antigen C2 (191-200)
Melanoma antigen preferentially expressed in tumors (142-151)
MAGE-4 (169-177)
MAGE-3 (267-282)
LPGAT1 (262-270)
MAGE-3 (111-126)
MAGE-3 (149-160)
MAGE-3 (281-295)
MAGE-6 (168-176)
MAGE-5 (5-12)
MAGE-4 (230-239)
MAGE-1 (281-292)
MAGE-3 (97-105)
Mammaglobin-A precursor (66-74)
MAGE-2 (212-220)
MAGE-2 (156-164)
Mammaglobin-A precursor (83-92)
MAGE-2 (157-166)
lymphocyte antigen 6 complex locus K (114-133)
Leukocyte Proteinase-3 (169-177)
MAGE-12 (114-127)
MART-1 (1-20)
MARK Substrate 847991-34-8
143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197
Copyright 2007©  ChemicalBook. All rights reserved.